Data from a long-term Scandinavian study show that the addition of radiation to long-term androgen deprivation therapy does not affect quality of life in patients with locally advanced prostate cancer. The long-term use of the antiandrogen flutamide might, however, have negatively affected quality of life outcomes for all patients in this study.
- Danil V. Makarov
- David F. Penson
